Abattis Bioceuticals Corp ATTBF

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

GREY:ATTBF - Post by User

Abattis Bioceuticals Corp

Bullboard Posts

Comment by fasttrack5on Jul 13, 2018 12:39am

120 Views

Post# 28310505

RE:Our take on Emh update

Emerald Health Therapeutics (TSXV: EMH) gave an update on its different strategy and progress. Emerald heath which is currently trading at 1/3 of its 52 week high and half the price of their last 2 raises explained its 3 pillar business plan. Emh who currently holds a cultivation licence for their, Village farm partnered, 1.1m sq foot facility explained that Product Innovation, Branding & Sales, and Production and Raw Material Sourcing are their key strategies for future profitability. They also mentioned that their 53% owned Northern Vine Labs (which Abattis Bioceuticals Corp (CSE: ATT) owns the other 47%) who has a Dealers Licence is key in helping EMH research new products and import and export dried cannabis internationally. Hopefully, in the near future, Northern Vine Labs will help provide revenue for Abattis and EMH, which will then see a much-needed increase in share prices for both companies. Just like Huge with their 75k sq foot Quebec indoor facility once fully expanded they will have over 1.5m sq feet of growing space.

Bullboard Posts

Golden Minerals closes Yoquivo gold-silver project sale